Stellora.AI Advances Quantum Flow to Support Healthcare, Drug Discovery, and Disease Research
View original at globenewswire.comStellora.AI Advances Quantum Flow to Support Healthcare, Drug Discovery, and Disease Research Prague, Czechia, May 25, 2026 (GLOBE NEWSWIRE) -- Stellora.AI, a deep-tech artificial intelligence startup developing advanced agentic AI and quantum workflow technology, today announced the continued advancement of Stellora.A…
Lo que extrajimos de esta fuente
The claims Via News extracted from this document. We point to the source; we don't replace it.
Stellora.AI is opening demo access because it wants serious partners to experience where the technology is going and how it can support meaningful scientific progress.
60% confidenceQuantum Flow is not intended to replace researchers, doctors, or pharmaceutical laboratories, but is being developed as a powerful workflow assistant for scientific teams.
60% confidenceQuantum Flow is designed to generate functional quantum circuits and quantum code tailored to specific research goals, working with scientific studies, quantum theories, target machine SDK documentation, and target quantum machine requirements.
60% confidenceWith Quantum Flow, Stellora.AI is building a bridge between validated research, quantum SDKs, and functional quantum circuits so researchers can move faster from idea to experimentation.
60% confidenceStellora.AI sees Quantum Flow as applicable for biomedical discovery, computational chemistry, precision medicine, and disease research where complex modeling and simulation are essential.
60% confidenceEvery improvement in Quantum Flow brings Stellora.AI closer to a future where AI can help scientists generate, test, and refine quantum workflows for healthcare, drug discovery, and disease research, with the goal of empowering researchers rather than replacing them.
60% confidenceStellora.AI was never created to be just another AI tool. Our mission is to help humanity by making advanced, trusted intelligence available for the most important scientific challenges.
60% confidence